يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Shivhare A"', وقت الاستعلام: 1.33s تنقيح النتائج
  1. 1
    Abstract PD4-07: Subcutaneous administration of the fixed-dose combination of trastuzumab and pertuzumab in combination with chemotherapy in HER2-positive early breast cancer: Primary analysis of the phase III, multicenter, randomized, open-label, two-arm FeDeriCa study

    المؤلفون: Whitney P. Kirschbrown, Daniil Stroyakovskii, Christian Jackisch, Christian Schem, Tanja Badovinac Crnjevic, Antoinette R. Tan, Zbigniew Nowecki, Michelino De Laurentiis, Kyung Hae Jung, Mahesh Shivhare, André Mattar, Seock-Ah Im, Sarah Heeson, Eleonora Restuccia, Ramon Colomer, Jean-Yves Pierga

    المصدر: Cancer Research. 80:PD4-07

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Chemotherapy, medicine.medical_specialty, Cyclophosphamide, business.industry, medicine.medical_treatment, Fixed-dose combination, Urology, medicine.disease, Loading dose, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Breast cancer, Oncology, Docetaxel, Trastuzumab, 030220 oncology & carcinogenesis, medicine, Pertuzumab, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b378256832d66d15933e5cd17777ed3f
    https://doi.org/10.1158/1538-7445.sabcs19-pd4-07

    أضف إلى المفضلة
  2. 2
    Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study

    المؤلفون: Christian Jackisch, Seock-Ah Im, Michelino De Laurentiis, Jean-Yves Pierga, Mahesh Shivhare, Ramon Colomer, Kyung Hae Jung, Tanja Badovinac Crnjevic, Alexandra Hogea, Daniil Stroyakovskii, Sarah Heeson, Antoinette R. Tan, Zbigniew Nowecki, André Mattar, Whitney P. Kirschbrown, Christian Schem, Eleonora Restuccia

    المساهمون: Tan, A. R., Im, S. -A., Mattar, A., Colomer, R., Stroyakovskii, D., Nowecki, Z., De Laurentiis, M., Pierga, J. -Y., Jung, K. H., Schem, C., Hogea, A., Badovinac Crnjevic, T., Heeson, S., Shivhare, M., Kirschbrown, W. P., Restuccia, E., Jackisch, C.

    المصدر: The Lancet. Oncology. 22(1)

    مصطلحات موضوعية: 0301 basic medicine, Adult, medicine.medical_specialty, Time Factors, Receptor, ErbB-2, medicine.medical_treatment, Injections, Subcutaneous, Population, Phases of clinical research, Hyaluronoglucosaminidase, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Loading dose, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Trastuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Humans, education, Neoadjuvant therapy, Neoplasm Staging, education.field_of_study, business.industry, Middle Aged, medicine.disease, Chemotherapy regimen, Neoadjuvant Therapy, 030104 developmental biology, Treatment Outcome, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Pertuzumab, business, Febrile neutropenia, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99e575a2761394ec388f6b5a6dee91bf
    https://pubmed.ncbi.nlm.nih.gov/33539750

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
  3. 3
    46P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study

    المؤلفون: M. De Laurentiis, Daniil Stroyakovskii, Antoinette R. Tan, Zbigniew Nowecki, Eleonora Restuccia, Christian Jackisch, Christian Schem, J-Y. Pierga, Kyung Hwa Jung, André Mattar, Mahesh Shivhare, Sarah Heeson, T. Badovinac Crnjevic, R. Colomer, A. Alexandrou, S-A. Im, Christian Aguila

    المصدر: Annals of Oncology. 32:S40-S41

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Fixed-dose combination, Hematology, Neo adjuvant, Subcutaneous injection, Trastuzumab, Internal medicine, Medicine, Pertuzumab, Open label, business, Adjuvant, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2829d67d9bbdf8f69eb27e6b4335ba09
    https://doi.org/10.1016/j.annonc.2021.03.060

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء